IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners L.P.

Q4 2017 Holdings

Filed 2018-04-25 | 3 holdings | $100.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Apellis Pharmaceuticals, IncCOM037530106$77.7K3,579,30577.1%
Nabriva Therapeutics PLCSHSG63637105$12.7K2,122,96212.6%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$10.4K875,00010.3%